1.
Blauvelt A, Eichenfeld L, Kuligowski M, Venturanza M, Sun K, Silverberg J. Long-term safety and disease control with ruxolitinib cream among patients with atopic dermatitis based on previous medication history: Pooled results from two phase 3 studies. J of Skin [Internet]. 2021Nov.5 [cited 2022Aug.8];5(6):s65. Available from: https://jofskin.org/index.php/skin/article/view/1416